These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18307785)

  • 1. The United States and Canada as a coupled epidemiological system: an example from hepatitis A.
    Amariei R; Willms AR; Bauch CT
    BMC Infect Dis; 2008 Feb; 8():23. PubMed ID: 18307785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A vaccination coverage among adults 18-49 years traveling to a country of high or intermediate endemicity, United States.
    Lu PJ; Byrd KK; Murphy TV
    Vaccine; 2013 May; 31(19):2348-57. PubMed ID: 23523408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A.
    Srinivasa Rao AS; Chen MH; Pham BZ; Tricco AC; Gilca V; Duval B; Krahn MD; Bauch CT
    BMC Infect Dis; 2006 Dec; 6():174. PubMed ID: 17147828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An estimate of the incidence of hepatitis A in unimmunized Canadian travelers to developing countries.
    Teitelbaum P
    J Travel Med; 2004; 11(2):102-6. PubMed ID: 15109475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient awareness of need for hepatitis a vaccination (prophylaxis) before international travel.
    Liu SJ; Sharapov U; Klevens M
    J Travel Med; 2015; 22(3):174-8. PubMed ID: 25619557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ethnicity and travel on Hepatitis A vaccination coverage and disease incidence in Arizona at the United States-Mexico Border.
    Ernst KC; Erhart LM
    Hum Vaccin Immunother; 2014; 10(5):1396-403. PubMed ID: 24603091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surveillance for acute viral hepatitis--United States, 2006.
    Wasley A; Grytdal S; Gallagher K;
    MMWR Surveill Summ; 2008 Mar; 57(2):1-24. PubMed ID: 18354374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.
    Van Effelterre TP; Zink TK; Hoet BJ; Hausdorff WP; Rosenthal P
    Clin Infect Dis; 2006 Jul; 43(2):158-64. PubMed ID: 16779741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dynamic model for assessing universal Hepatitis A vaccination in Canada.
    Bauch CT; Rao AS; Pham BZ; Krahn M; Gilca V; Duval B; Chen MH; Tricco AC
    Vaccine; 2007 Feb; 25(10):1719-26. PubMed ID: 17229493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old.
    Duval B; De Serres G; Ochnio J; Scheifele D; Gîlca V
    Pediatr Infect Dis J; 2005 Jun; 24(6):514-9. PubMed ID: 15933561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of hepatitis A antibodies among Israeli travellers and the economic feasibility of screening before vaccination.
    Schwartz E; Raveh D
    Int J Epidemiol; 1998 Feb; 27(1):118-20. PubMed ID: 9563704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A risk in travelers.
    Askling HH; Rombo L; Andersson Y; Martin S; Ekdahl K
    J Travel Med; 2009; 16(4):233-8. PubMed ID: 19674261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and risk factors of hepatitis A in Catalonia after the introduction of a hepatitis A+B vaccination programme.
    Godoy P; Carmona G; Manzanares S; Jane M; Borràs E; Camps N; Álvarez J; Barrabeig I; Sala MR; Rius C; Minguell S; Carol M; Ferras J; Domínguez A;
    J Viral Hepat; 2018 Sep; 25(9):1001-1007. PubMed ID: 29603832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT; Anonychuk AM; Pham BZ; Gilca V; Duval B; Krahn MD
    Vaccine; 2007 Dec; 25(51):8536-48. PubMed ID: 17996339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A virus infections in travelers, 1988-2004.
    Mutsch M; Spicher VM; Gut C; Steffen R
    Clin Infect Dis; 2006 Feb; 42(4):490-7. PubMed ID: 16421793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of universal childhood hepatitis A vaccination in Brazil: regional analyses according to the endemic context.
    Sartori AM; de Soárez PC; Novaes HM; Amaku M; de Azevedo RS; Moreira RC; Pereira LM; Ximenes RA; Martelli CM
    Vaccine; 2012 Dec; 30(52):7489-97. PubMed ID: 23107593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the decline and future of hepatitis A transmission in Australia.
    Jayasundara D; Hui BB; Regan DG; Heywood AE; MacIntyre CR; Wood JG
    J Viral Hepat; 2019 Jan; 26(1):199-207. PubMed ID: 30315680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public Health Impact and Cost-Effectiveness of Hepatitis A Vaccination in the United States: A Disease Transmission Dynamic Modeling Approach.
    Dhankhar P; Nwankwo C; Pillsbury M; Lauschke A; Goveia MG; Acosta CJ; Elbasha EH
    Value Health; 2015 Jun; 18(4):358-67. PubMed ID: 26091589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes to country-specific hepatitis A travel vaccination recommendation for UK travellers in 2017-responding to a vaccine shortage in the national context.
    Petersen J; Freedman J; Ford L; Gawthrop M; Simons H; Edelstein M; Plunkett J; Balogun K; Mandal S; Patel D
    Public Health; 2019 Mar; 168():150-156. PubMed ID: 30442468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.